Shares of ANGLE plc (LON:AGL – Get Free Report) fell 24.9% on Wednesday . The stock traded as low as GBX 2.06 ($0.03) and last traded at GBX 2.07 ($0.03). 2,604,949 shares were traded during trading, an increase of 85% from the average session volume of 1,407,206 shares. The stock had previously closed at GBX 2.75 ($0.04).
ANGLE Price Performance
The stock has a 50 day moving average of GBX 4.88 and a two-hundred day moving average of GBX 6.85. The stock has a market cap of £6.79 million, a PE ratio of -43.83 and a beta of 0.22. The company has a debt-to-equity ratio of 17.22, a quick ratio of 6.18 and a current ratio of 5.19.
ANGLE (LON:AGL – Get Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The company reported GBX (2.87) earnings per share for the quarter. ANGLE had a negative return on equity of 76.01% and a negative net margin of 890.91%. Equities analysts anticipate that ANGLE plc will post -8.6599997 EPS for the current year.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Featured Articles
- Five stocks we like better than ANGLE
- 5 discounted opportunities for dividend growth investors
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
